The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic

[1]  Päivi Heikkilä,et al.  CHEK2 variant I157T may be associated with increased breast cancer risk , 2004, International journal of cancer.

[2]  P. Radice,et al.  The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy , 2004, Human mutation.

[3]  A. Meindl,et al.  Limited relevance of the CHEK2 gene in hereditary breast cancer , 2004, International journal of cancer.

[4]  Nazneen Rahman,et al.  CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. , 2004, American journal of human genetics.

[5]  J. Lubiński,et al.  A novel founder CHEK2 mutation is associated with increased prostate cancer risk. , 2004, Cancer research.

[6]  L. Forétova,et al.  BRCA1 and BRCA2 mutations in women with familial or early‐onset breast/ovarian cancer in the Czech Republic , 2004, Human mutation.

[7]  E. Friedman,et al.  CHEK2*1100delC and male breast cancer risk in Israel , 2004, International journal of cancer.

[8]  J. Klijn,et al.  The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. , 2003, American journal of human genetics.

[9]  M. Zikan,et al.  Mutations of the BRCA1 Gene in Hereditary Breast and Ovarian Cancer in the Czech Republic , 2003, Medical Principles and Practice.

[10]  P. Gregersen,et al.  Frequency of CHEK2*1100delC in New York breast cancer cases and controls , 2003, BMC Medical Genetics.

[11]  O. Kallioniemi,et al.  A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. , 2002, American journal of human genetics.

[12]  R. Eeles,et al.  A robust method for detecting CHK2/RAD53 mutations in genomic DNA , 2002, Human mutation.

[13]  J. Benítez,et al.  The breast cancer low‐penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population , 2004, International journal of cancer.

[14]  J. Klijn,et al.  Excess Risk for Contralateral Breast Cancer in CHEK2*1100delC Germline Mutation Carriers , 2004, Breast Cancer Research and Treatment.